Goelzer Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.89M Sell
4,877
-390
-7% -$145K 0.08% 141
2026
Q1
$1.54M Buy
5,267
+4,235
+410% +$1.39M 0.07% 147
2025
Q4
$362K Sell
1,032
-20
-2% -$6.76K 0.02% 230
2025
Q3
$340K Sell
1,052
-280
-21% -$87.1K 0.02% 215
2025
Q2
$518K Buy
1,332
+508
+62% +$204K 0.03% 183
2025
Q1
$358K Buy
824
+142
+21% +$57K 0.02% 200
2024
Q4
$252K Hold
682
0.01% 228
2024
Q3
$355K Hold
682
0.02% 199
2024
Q2
$370K Hold
682
0.02% 191
2024
Q1
$354K Buy
682
+55
+9% +$27.4K 0.02% 206
2023
Q4
$296K Buy
+627
New +$290K 0.02% 213
2023
Q1
Sell
-426
Closed -$219K 230
2022
Q4
$219K Buy
+426
New +$216K 0.02% 228
2022
Q3
Sell
-426
Closed -$206K 225
2022
Q2
$206K Hold
426
0.02% 215
2022
Q1
$209K Buy
+426
New +$195K 0.02% 211
2021
Q1
Sell
-1,106
Closed -$355K 202
2020
Q4
$355K Sell
1,106
-32
-3% -$9.82K 0.03% 180
2020
Q3
$306K Hold
1,138
0.03% 217
2020
Q2
$299K Hold
1,138
0.03% 211
2020
Q1
$258K Buy
1,138
+9
+0.8% +$2.45K 0.03% 220
2019
Q4
$341K Sell
1,129
-10
-0.9% -$2.75K 0.03% 217
2019
Q3
$273K Buy
1,139
+8
+0.7% +$2.19K 0.03% 228
2019
Q2
$319K Buy
1,131
+409
+57% +$112K 0.03% 219
2019
Q1
$207K Buy
+722
New +$209K 0.02% 262
2015
Q4
Sell
-9,767
Closed -$1.37M 200
2015
Q3
$1.37M Buy
9,767
+160
+2% +$24K 0.22% 139
2015
Q2
$1.58M Buy
+9,607
New +$1.53M 0.24% 133

Other funds holding ELV

Goelzer Investment Management's ELV Position: Q2 2026 in Review

Goelzer Investment Management reduced its Elevance Health (ELV) stake by 7.4% in Q2 2026, selling an estimated $145K and leaving 4,877 shares worth $1.89M. The position accounts for 0.08% of the portfolio, ranked #141.

Goelzer Investment Management first reported a position in ELV in Q2 2015 and has held it in 24 quarters since. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Goelzer Investment Management held 4,877 shares of Elevance Health worth $1.89M as of Q2 2026.
  • Goelzer Investment Management sold 390 Elevance Health shares in Q2 2026, an estimated $145K.
  • Elevance Health made up 0.08% of Goelzer Investment Management's portfolio in Q2 2026, its #141 holding.
  • Goelzer Investment Management first reported a position in Elevance Health in Q2 2015 and has held it in 24 quarters since.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Goelzer Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.